Drug Shortage Report for HIBERIX
| Report ID | 29521 |
| Drug Identification Number | 02239200 |
| Brand name | HIBERIX |
| Common or Proper name | Haemophilus influenzae type b (Hib) conjugate vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE |
| Strength(s) | 10MCG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1's |
| ATC code | J07AG |
| ATC description | BACTERIAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2017-11-16 |
| Estimated end date | 2017-12-07 |
| Actual end date | 2017-12-04 |
| Shortage status | Resolved |
| Updated date | 2017-12-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2017-12-06 | French | Compare |
| v5 | 2017-12-06 | English | Compare |
| v4 | 2017-12-01 | French | Compare |
| v3 | 2017-12-01 | English | Compare |
| v2 | 2017-11-17 | French | Compare |
| v1 | 2017-11-17 | English | Compare |
Showing 1 to 6 of 6